Higher prices and parts shortage for new buses impact London Transit service improvements
Emerging economic pressures are tightening their squeeze on London Transit.
Inflation will take a bigger bite out of the budget for new city buses and supply chain shortages will delay this year’s planned service improvements.
New Flyer, which has a contract to manufacture 22 buses for London Transit, has advised that due to a global computer chip shortage, delivery of 17 replacement buses and a five bus service expansion won’t be completed until the first quarter of 2023.
According to a report to the London Transit Commission (LTC), delaying the five expansion buses, “will limit the ability to implement the 2022 service improvements until such time as the buses have been received and prepped for service.”
Meanwhile, the cost of new buses has climbed.
A letter sent to London Transit explains that New Flyer is adding seven per cent to the contract price of the 22 buses ordered by London Transit — the combined total will increase $995,900.
The letter blames rapid inflation being experienced including:
- raw material shortages and resulting price escalation;
- price increases and surcharges from major component suppliers;
- delays, shortages and exorbitant premiums paid on the broker market for microchip and electronic component supply; and
- escalating freight costs.
New Flyer explains that the seven per cent increase will not offset all of the inflationary costs that the company is experiencing.
London Transit will cover the bulk of the additional cost with provincial gas tax revenue and other senior government funding.
The LTC will receive the report about the delivery schedule and higher costs at its meeting on June 29.
CTVNews.ca Top Stories
BREAKING Israel attacks Iran, Reuters sources say; drones reported over Isfahan
Israel has attacked Iran, three people familiar with the matter told Reuters, as Iranian state media reported early on Friday that its forces had destroyed drones, days after Iran launched a retaliatory drone strike on Israel.
American millionaire Jonathan Lehrer denied bail after being charged with killing Canadian couple
American millionaire Jonathan Lehrer, one of two men charged in the killings of a Canadian couple in Dominica, has been denied bail.
Nearly half of China's major cities are sinking, researchers say
Nearly half of China's major cities are suffering 'moderate to severe' levels of subsidence, putting millions at risk of flooding especially as sea levels rise.
Prince Harry formally confirms he is now a U.S. resident
Prince Harry, the son of King Charles III and fifth in line to the British throne, has formally confirmed he is now a U.S. resident.
Judge says 'no evidence fully supports' murder case against Umar Zameer as jury starts deliberations
The judge presiding over the trial of a man accused of fatally running over a Toronto police officer is telling jurors the possible verdicts they may reach based on the evidence in the case.
Health Canada to change sperm donor screening rules for men who have sex with men
Health Canada will change its longstanding policy restricting gay and bisexual men from donating to sperm banks in Canada, CTV News has learned. The federal health agency has adopted a revised directive removing the ban on gay, bisexual and other men who have sex with men, effective May 8.
Colin Jost names one celebrity who is great at hosting 'Saturday Night Live'
Colin Jost, who co-anchors Saturday Night Live's 'Weekend Update,' revealed who he thinks is one of the best hosts on the show.
Sports columnist apologizes for 'oafish' comments directed at Caitlin Clark. The controversy isn't over
A male columnist has apologized for a cringeworthy moment during former University of Iowa superstar and college basketball's highest scorer Caitlin Clark's first news conference as an Indiana Fever player.
'Shopaholic' author Sophie Kinsella reveals brain cancer diagnosis
Sophie Kinsella, the best-selling author behind the 'Shopaholic' book series, has revealed that she is receiving treatment for brain cancer.